Mariner Wealth Advisors »

Outlook Therapeutics shares owned by Mariner Wealth Advisors

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Mariner Wealth Advisors from 13F filings

Historical chart of Mariner Wealth Advisors investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Mariner Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Mariner Wealth Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.1k 15k 0.39

More positions owned by Mariner Wealth Advisors

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Tesla Motors (TSLA)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Us Aggbd Et (AGG)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for Mariner Wealth Advisors

Top funds holding Outlook Therapeutics

Vanguard Group
Charles Schwab Investment Management
Rosalind Advisors
Scotia Capital
Millennium Management
Bank of America Corporation
Barclays
Rhumbline Advisers
Gables Capital Management
UBS Group
Ancora Advisors
Jpmorgan Chase & Co
Alliancebernstein
American International
Captrust Financial Advisors

View all funds holding Outlook Therapeutics